Learn how Scotland is already embedding AI into health infrastructure and improving the quality efficiency and sustainability of healthcare. Additionally, attendees will gain insight into the proven benefits of AI in breast cancer screening and find out what is next following successful trials.
Prof David Lowe
Clinical director for health innovation, Scottish Health and Industry Partnership (SHIP) and Honorary Professor (School of Health & Wellbeing), University of Glasgow
Professor David J Lowe is Clinical Director Innovation University of Glasgow, Emergency Consultant at Queen Elizabeth University Hospital, Glasgow and Clinical Lead for Health Innovation for Scottish Government. David has significant experience of creating the infrastructure and conditions to develop innovative devices, services and solutions with a range of industry and academic partners both UK and worldwide. He is clinical lead for a number of projects with DHVL and previously iCAIRD including ensemble based AI techniques for COVID, osteoporosis as well as supporting evaluation and development of AI solutions across a range of imaging modalities. He leads on range of projects including trauma for the STN (thetraumaapp.com), Dynamic COPD (support.nhscopd.scot) and OPERA(early diagnostic heart failure utilising AI). Such projects focus on developing AI/ML clinical decision support by embedding a data driven approach combined with patient co-management into clinical care pathways. David also established the EmQuire research group focusing on data, device and decisions within Emergency Medicine.
Dr Gerald Lip
Clinical director for breast cancer screening, North East of Scotland and the Chief investigator in the mammography artificial intelligence project, Industrial Centre for Artificial Intelligence and Digital Diagnostics Scotland
Speakers to be announced.
